Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
424.50    4.00 (0.95%)
Bid:
425.00
Ask:
426.00
Spread: 1.00 (0.235%)
Market Cap: £1.38b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Issue of Equity

22 Mar 2022 16:42

Fidelity Special Values Plc - Issue of Equity

Fidelity Special Values Plc - Issue of Equity

PR Newswire

London, March 22

Fidelity Special Values PLC

Issue of Ordinary Shares

On 22 March 2022, Fidelity Special Values PLC (the “Company”) issued from its block listing facility of 14 December 2020, a total of 185,000 new shares, 50,000 at a price of 293.60 pence per share and 135,000 at a price of 294.00 pence per share. These shares rank pari passu with the existing Ordinary shares in issue.

Following this issue, there are 1,095,000 Ordinary shares available under the Company’s block listing facility of 14 December 2020. In addition, the Company also has 30,000,000 ordinary shares under its block listing facility of 7 February 2022.

As a result of this issue, the total number of Ordinary shares in issue now stands at 323,918,920. There are no shares held in Treasury, therefore the total number of Ordinary shares with voting rights in the Company is 323,918,920.

The above figure of Ordinary shares with voting rights (323,918,920) may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Smita Amin

For and on behalf of FIL Investments International

Company Secretary

01737 836347

22 March 2022

Date   Source Headline
29th Apr 20258:09 amRNSNet Asset Value(s)
28th Apr 20258:11 amRNSNet Asset Value(s)
28th Apr 20257:30 amPRNDividend Declaration
28th Apr 20257:00 amPRNHalf-year Report
25th Apr 20257:32 amRNSNet Asset Value(s)
24th Apr 20258:00 amRNSNet Asset Value(s)
23rd Apr 20257:56 amRNSNet Asset Value(s)
22nd Apr 20253:35 pmPRNMonthly Factsheet
22nd Apr 20257:46 amRNSNet Asset Value(s)
17th Apr 20257:51 amRNSNet Asset Value(s)
16th Apr 20257:56 amRNSNet Asset Value(s)
15th Apr 20257:49 amRNSNet Asset Value(s)
14th Apr 20257:56 amRNSNet Asset Value(s)
11th Apr 20257:41 amRNSNet Asset Value(s)
10th Apr 20257:40 amRNSNet Asset Value(s)
9th Apr 20257:39 amRNSNet Asset Value(s)
8th Apr 20257:59 amRNSNet Asset Value(s)
7th Apr 20258:04 amRNSNet Asset Value(s)
4th Apr 20257:55 amRNSNet Asset Value(s)
3rd Apr 20252:11 pmPRNPortfolio Update
3rd Apr 20257:39 amRNSNet Asset Value(s)
2nd Apr 20257:33 amRNSNet Asset Value(s)
1st Apr 20254:13 pmPRNTotal Voting Rights
1st Apr 20258:30 amRNSNet Asset Value(s)
31st Mar 20257:53 amRNSNet Asset Value(s)
28th Mar 20257:50 amRNSNet Asset Value(s)
27th Mar 20257:31 amRNSNet Asset Value(s)
26th Mar 20255:26 pmPRNTransaction in Own Shares
26th Mar 20257:31 amRNSNet Asset Value(s)
25th Mar 20257:38 amRNSNet Asset Value(s)
25th Mar 20257:30 amPRNCompliance with Market Abuse Regulations
24th Mar 20256:13 pmPRNMonthly Factsheet
24th Mar 20257:29 amRNSNet Asset Value(s)
21st Mar 20257:46 amRNSNet Asset Value(s)
20th Mar 20257:21 amRNSNet Asset Value(s)
19th Mar 20257:27 amRNSNet Asset Value(s)
18th Mar 20258:04 amRNSNet Asset Value(s)
17th Mar 20257:36 amRNSNet Asset Value(s)
14th Mar 20257:46 amRNSNet Asset Value(s)
13th Mar 20257:31 amRNSNet Asset Value(s)
12th Mar 20257:32 amRNSNet Asset Value(s)
11th Mar 20257:43 amRNSNet Asset Value(s)
10th Mar 20257:53 amRNSNet Asset Value(s)
7th Mar 20257:33 amRNSNet Asset Value(s)
6th Mar 20257:30 amRNSNet Asset Value(s)
5th Mar 20257:56 amRNSNet Asset Value(s)
4th Mar 20257:47 amRNSNet Asset Value(s)
3rd Mar 20256:16 pmPRNTotal Voting Rights
3rd Mar 20257:38 amRNSNet Asset Value(s)
28th Feb 20255:04 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.